Characteristics of sleep disturbances in japanese patients with parkinson's disease. A study using Parkinson's disease sleep scale
Identifieur interne : 001623 ( PascalFrancis/Corpus ); précédent : 001622; suivant : 001624Characteristics of sleep disturbances in japanese patients with parkinson's disease. A study using Parkinson's disease sleep scale
Auteurs : Keisuke Suzuki ; Yasuyuki Okuma ; Nobutaka Hattori ; Satoshi Kamei ; Fumihito Yoshii ; Hiroya Utsumi ; Yasuo Iwasaki ; Mutsumi Iijima ; Tomoyuki Miyamoto ; Masayuki Miyamoto ; Koichi HirataSource :
- Movement disorders [ 0885-3185 ] ; 2007.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
Abstract
The present multicenter cross-sectional study was performed using semistructured questionnaires to determine the contributing factors of sleep disturbances in Japanese patients with Parkinson's disease (PD). We used the Parkinson's disease sleep scale (PDSS, Japanese version). All data were obtained by means of interviewed questionnaire and physical examination by neurologists. The study was carried out between April 2005 and December 2005 at eight university hospitals and affiliated facilities in the Kanto area of Japan. A total of 188 (85 men and 103 women) PD patients and 144 controls (64 men and 80 women) were included. Stepwise regression analysis identified complications of treatment, depression, age, and disease duration as significant risk factors of sleep disturbances in PD. Significant differences in total PDSS score were observed between Hoehn & Yahr (H&Y) Stages 1 and 4, between H&Y Stages 2 and 4, and between H&Y stages 3 and 4 (Bonferroni test). The results of this survey suggested that complications due to treatment (dyskinesia, wearing off, on-off), depressive state, and disease stage are significant determinants of sleep disorders in Japanese patients with PD. We speculate that the reduction of neurotransmitters involved in the sleep-wakefulness mechanism and degeneration of neurons progress together in parallel with deterioration of motor function.
Notice en format standard (ISO 2709)
Pour connaître la documentation sur le format Inist Standard.
pA |
|
---|
Format Inist (serveur)
NO : | PASCAL 07-0391073 INIST |
---|---|
ET : | Characteristics of sleep disturbances in japanese patients with parkinson's disease. A study using Parkinson's disease sleep scale |
AU : | SUZUKI (Keisuke); OKUMA (Yasuyuki); HATTORI (Nobutaka); KAMEI (Satoshi); YOSHII (Fumihito); UTSUMI (Hiroya); IWASAKI (Yasuo); IIJIMA (Mutsumi); MIYAMOTO (Tomoyuki); MIYAMOTO (Masayuki); HIRATA (Koichi) |
AF : | Department of Neurology, Dokkyo Medical University/Tochigi/Japon (1 aut., 9 aut., 10 aut., 11 aut.); Department of Neurology, Juntendo University Shizuoka Hospital/Tokyo/Japon (2 aut.); Department of Neurology, Juntendo University School of Medicine/Tokyo/Japon (3 aut.); Division of Neurology, Department of Medicine, Nihon University School of Medicine/Tokyo/Japon (4 aut.); Department of Neurology, Tokai University School of Medicine/Kanagawa/Japon (5 aut.); Third Department of Internal Medicine, Division of Neurology , Tokyo Medical University, School of Medicine/Tokyo/Japon (6 aut.); Department of Neurology, Toho University Omori Hospital/Tokyo/Japon (7 aut.); Department of Neurology, Tokyo Women's Medical University/Tokyo/Japon (8 aut.) |
DT : | Publication en série; Niveau analytique |
SO : | Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2007; Vol. 22; No. 9; Pp. 1245-1251; Bibl. 32 ref. |
LA : | Anglais |
EA : | The present multicenter cross-sectional study was performed using semistructured questionnaires to determine the contributing factors of sleep disturbances in Japanese patients with Parkinson's disease (PD). We used the Parkinson's disease sleep scale (PDSS, Japanese version). All data were obtained by means of interviewed questionnaire and physical examination by neurologists. The study was carried out between April 2005 and December 2005 at eight university hospitals and affiliated facilities in the Kanto area of Japan. A total of 188 (85 men and 103 women) PD patients and 144 controls (64 men and 80 women) were included. Stepwise regression analysis identified complications of treatment, depression, age, and disease duration as significant risk factors of sleep disturbances in PD. Significant differences in total PDSS score were observed between Hoehn & Yahr (H&Y) Stages 1 and 4, between H&Y Stages 2 and 4, and between H&Y stages 3 and 4 (Bonferroni test). The results of this survey suggested that complications due to treatment (dyskinesia, wearing off, on-off), depressive state, and disease stage are significant determinants of sleep disorders in Japanese patients with PD. We speculate that the reduction of neurotransmitters involved in the sleep-wakefulness mechanism and degeneration of neurons progress together in parallel with deterioration of motor function. |
CC : | 002B17; 002B17G; 002B17A03 |
FD : | Système nerveux pathologie; Trouble sommeil; Parkinson maladie; Etat dépressif; Japonais; Homme; Sommeil; Complication; Traitement |
FG : | Trouble neurologique; Encéphale pathologie; Extrapyramidal syndrome; Maladie dégénérative; Système nerveux central pathologie; Cycle veille sommeil; Trouble humeur |
ED : | Nervous system diseases; Sleep disorder; Parkinson disease; Depression; Japanese; Human; Sleep; Complication; Treatment |
EG : | Neurological disorder; Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Central nervous system disease; Sleep wake cycle; Mood disorder |
SD : | Sistema nervioso patología; Trastorno sueño; Parkinson enfermedad; Estado depresivo; Japonés; Hombre; Sueño; Complicación; Tratamiento |
LO : | INIST-20953.354000146732490060 |
ID : | 07-0391073 |
Links to Exploration step
Pascal:07-0391073Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Characteristics of sleep disturbances in japanese patients with parkinson's disease. A study using Parkinson's disease sleep scale</title>
<author><name sortKey="Suzuki, Keisuke" sort="Suzuki, Keisuke" uniqKey="Suzuki K" first="Keisuke" last="Suzuki">Keisuke Suzuki</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology, Dokkyo Medical University</s1>
<s2>Tochigi</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Okuma, Yasuyuki" sort="Okuma, Yasuyuki" uniqKey="Okuma Y" first="Yasuyuki" last="Okuma">Yasuyuki Okuma</name>
<affiliation><inist:fA14 i1="02"><s1>Department of Neurology, Juntendo University Shizuoka Hospital</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Hattori, Nobutaka" sort="Hattori, Nobutaka" uniqKey="Hattori N" first="Nobutaka" last="Hattori">Nobutaka Hattori</name>
<affiliation><inist:fA14 i1="03"><s1>Department of Neurology, Juntendo University School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Kamei, Satoshi" sort="Kamei, Satoshi" uniqKey="Kamei S" first="Satoshi" last="Kamei">Satoshi Kamei</name>
<affiliation><inist:fA14 i1="04"><s1>Division of Neurology, Department of Medicine, Nihon University School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Yoshii, Fumihito" sort="Yoshii, Fumihito" uniqKey="Yoshii F" first="Fumihito" last="Yoshii">Fumihito Yoshii</name>
<affiliation><inist:fA14 i1="05"><s1>Department of Neurology, Tokai University School of Medicine</s1>
<s2>Kanagawa</s2>
<s3>JPN</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Utsumi, Hiroya" sort="Utsumi, Hiroya" uniqKey="Utsumi H" first="Hiroya" last="Utsumi">Hiroya Utsumi</name>
<affiliation><inist:fA14 i1="06"><s1>Third Department of Internal Medicine, Division of Neurology , Tokyo Medical University, School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Iwasaki, Yasuo" sort="Iwasaki, Yasuo" uniqKey="Iwasaki Y" first="Yasuo" last="Iwasaki">Yasuo Iwasaki</name>
<affiliation><inist:fA14 i1="07"><s1>Department of Neurology, Toho University Omori Hospital</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Iijima, Mutsumi" sort="Iijima, Mutsumi" uniqKey="Iijima M" first="Mutsumi" last="Iijima">Mutsumi Iijima</name>
<affiliation><inist:fA14 i1="08"><s1>Department of Neurology, Tokyo Women's Medical University</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Miyamoto, Tomoyuki" sort="Miyamoto, Tomoyuki" uniqKey="Miyamoto T" first="Tomoyuki" last="Miyamoto">Tomoyuki Miyamoto</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology, Dokkyo Medical University</s1>
<s2>Tochigi</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Miyamoto, Masayuki" sort="Miyamoto, Masayuki" uniqKey="Miyamoto M" first="Masayuki" last="Miyamoto">Masayuki Miyamoto</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology, Dokkyo Medical University</s1>
<s2>Tochigi</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Hirata, Koichi" sort="Hirata, Koichi" uniqKey="Hirata K" first="Koichi" last="Hirata">Koichi Hirata</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology, Dokkyo Medical University</s1>
<s2>Tochigi</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">07-0391073</idno>
<date when="2007">2007</date>
<idno type="stanalyst">PASCAL 07-0391073 INIST</idno>
<idno type="RBID">Pascal:07-0391073</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001623</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Characteristics of sleep disturbances in japanese patients with parkinson's disease. A study using Parkinson's disease sleep scale</title>
<author><name sortKey="Suzuki, Keisuke" sort="Suzuki, Keisuke" uniqKey="Suzuki K" first="Keisuke" last="Suzuki">Keisuke Suzuki</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology, Dokkyo Medical University</s1>
<s2>Tochigi</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Okuma, Yasuyuki" sort="Okuma, Yasuyuki" uniqKey="Okuma Y" first="Yasuyuki" last="Okuma">Yasuyuki Okuma</name>
<affiliation><inist:fA14 i1="02"><s1>Department of Neurology, Juntendo University Shizuoka Hospital</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Hattori, Nobutaka" sort="Hattori, Nobutaka" uniqKey="Hattori N" first="Nobutaka" last="Hattori">Nobutaka Hattori</name>
<affiliation><inist:fA14 i1="03"><s1>Department of Neurology, Juntendo University School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Kamei, Satoshi" sort="Kamei, Satoshi" uniqKey="Kamei S" first="Satoshi" last="Kamei">Satoshi Kamei</name>
<affiliation><inist:fA14 i1="04"><s1>Division of Neurology, Department of Medicine, Nihon University School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Yoshii, Fumihito" sort="Yoshii, Fumihito" uniqKey="Yoshii F" first="Fumihito" last="Yoshii">Fumihito Yoshii</name>
<affiliation><inist:fA14 i1="05"><s1>Department of Neurology, Tokai University School of Medicine</s1>
<s2>Kanagawa</s2>
<s3>JPN</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Utsumi, Hiroya" sort="Utsumi, Hiroya" uniqKey="Utsumi H" first="Hiroya" last="Utsumi">Hiroya Utsumi</name>
<affiliation><inist:fA14 i1="06"><s1>Third Department of Internal Medicine, Division of Neurology , Tokyo Medical University, School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Iwasaki, Yasuo" sort="Iwasaki, Yasuo" uniqKey="Iwasaki Y" first="Yasuo" last="Iwasaki">Yasuo Iwasaki</name>
<affiliation><inist:fA14 i1="07"><s1>Department of Neurology, Toho University Omori Hospital</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Iijima, Mutsumi" sort="Iijima, Mutsumi" uniqKey="Iijima M" first="Mutsumi" last="Iijima">Mutsumi Iijima</name>
<affiliation><inist:fA14 i1="08"><s1>Department of Neurology, Tokyo Women's Medical University</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Miyamoto, Tomoyuki" sort="Miyamoto, Tomoyuki" uniqKey="Miyamoto T" first="Tomoyuki" last="Miyamoto">Tomoyuki Miyamoto</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology, Dokkyo Medical University</s1>
<s2>Tochigi</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Miyamoto, Masayuki" sort="Miyamoto, Masayuki" uniqKey="Miyamoto M" first="Masayuki" last="Miyamoto">Masayuki Miyamoto</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology, Dokkyo Medical University</s1>
<s2>Tochigi</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Hirata, Koichi" sort="Hirata, Koichi" uniqKey="Hirata K" first="Koichi" last="Hirata">Koichi Hirata</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology, Dokkyo Medical University</s1>
<s2>Tochigi</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2007">2007</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Complication</term>
<term>Depression</term>
<term>Human</term>
<term>Japanese</term>
<term>Nervous system diseases</term>
<term>Parkinson disease</term>
<term>Sleep</term>
<term>Sleep disorder</term>
<term>Treatment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Système nerveux pathologie</term>
<term>Trouble sommeil</term>
<term>Parkinson maladie</term>
<term>Etat dépressif</term>
<term>Japonais</term>
<term>Homme</term>
<term>Sommeil</term>
<term>Complication</term>
<term>Traitement</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The present multicenter cross-sectional study was performed using semistructured questionnaires to determine the contributing factors of sleep disturbances in Japanese patients with Parkinson's disease (PD). We used the Parkinson's disease sleep scale (PDSS, Japanese version). All data were obtained by means of interviewed questionnaire and physical examination by neurologists. The study was carried out between April 2005 and December 2005 at eight university hospitals and affiliated facilities in the Kanto area of Japan. A total of 188 (85 men and 103 women) PD patients and 144 controls (64 men and 80 women) were included. Stepwise regression analysis identified complications of treatment, depression, age, and disease duration as significant risk factors of sleep disturbances in PD. Significant differences in total PDSS score were observed between Hoehn & Yahr (H&Y) Stages 1 and 4, between H&Y Stages 2 and 4, and between H&Y stages 3 and 4 (Bonferroni test). The results of this survey suggested that complications due to treatment (dyskinesia, wearing off, on-off), depressive state, and disease stage are significant determinants of sleep disorders in Japanese patients with PD. We speculate that the reduction of neurotransmitters involved in the sleep-wakefulness mechanism and degeneration of neurons progress together in parallel with deterioration of motor function.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA05><s2>22</s2>
</fA05>
<fA06><s2>9</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Characteristics of sleep disturbances in japanese patients with parkinson's disease. A study using Parkinson's disease sleep scale</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>SUZUKI (Keisuke)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>OKUMA (Yasuyuki)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>HATTORI (Nobutaka)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>KAMEI (Satoshi)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>YOSHII (Fumihito)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>UTSUMI (Hiroya)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>IWASAKI (Yasuo)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>IIJIMA (Mutsumi)</s1>
</fA11>
<fA11 i1="09" i2="1"><s1>MIYAMOTO (Tomoyuki)</s1>
</fA11>
<fA11 i1="10" i2="1"><s1>MIYAMOTO (Masayuki)</s1>
</fA11>
<fA11 i1="11" i2="1"><s1>HIRATA (Koichi)</s1>
</fA11>
<fA14 i1="01"><s1>Department of Neurology, Dokkyo Medical University</s1>
<s2>Tochigi</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
<sZ>11 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Department of Neurology, Juntendo University Shizuoka Hospital</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Department of Neurology, Juntendo University School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Division of Neurology, Department of Medicine, Nihon University School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="05"><s1>Department of Neurology, Tokai University School of Medicine</s1>
<s2>Kanagawa</s2>
<s3>JPN</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="06"><s1>Third Department of Internal Medicine, Division of Neurology , Tokyo Medical University, School of Medicine</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="07"><s1>Department of Neurology, Toho University Omori Hospital</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="08"><s1>Department of Neurology, Tokyo Women's Medical University</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>8 aut.</sZ>
</fA14>
<fA20><s1>1245-1251</s1>
</fA20>
<fA21><s1>2007</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000146732490060</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2007 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>32 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>07-0391073</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>The present multicenter cross-sectional study was performed using semistructured questionnaires to determine the contributing factors of sleep disturbances in Japanese patients with Parkinson's disease (PD). We used the Parkinson's disease sleep scale (PDSS, Japanese version). All data were obtained by means of interviewed questionnaire and physical examination by neurologists. The study was carried out between April 2005 and December 2005 at eight university hospitals and affiliated facilities in the Kanto area of Japan. A total of 188 (85 men and 103 women) PD patients and 144 controls (64 men and 80 women) were included. Stepwise regression analysis identified complications of treatment, depression, age, and disease duration as significant risk factors of sleep disturbances in PD. Significant differences in total PDSS score were observed between Hoehn & Yahr (H&Y) Stages 1 and 4, between H&Y Stages 2 and 4, and between H&Y stages 3 and 4 (Bonferroni test). The results of this survey suggested that complications due to treatment (dyskinesia, wearing off, on-off), depressive state, and disease stage are significant determinants of sleep disorders in Japanese patients with PD. We speculate that the reduction of neurotransmitters involved in the sleep-wakefulness mechanism and degeneration of neurons progress together in parallel with deterioration of motor function.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B17</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B17G</s0>
</fC02>
<fC02 i1="03" i2="X"><s0>002B17A03</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Trouble sommeil</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Sleep disorder</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Trastorno sueño</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Parkinson maladie</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Etat dépressif</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Depression</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Estado depresivo</s0>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Japonais</s0>
<s5>09</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Japanese</s0>
<s5>09</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Japonés</s0>
<s5>09</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Homme</s0>
<s5>10</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Human</s0>
<s5>10</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Hombre</s0>
<s5>10</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Sommeil</s0>
<s5>11</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Sleep</s0>
<s5>11</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Sueño</s0>
<s5>11</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Complication</s0>
<s5>12</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Complication</s0>
<s5>12</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Complicación</s0>
<s5>12</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Traitement</s0>
<s5>13</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Treatment</s0>
<s5>13</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Tratamiento</s0>
<s5>13</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Trouble neurologique</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Neurological disorder</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Trastorno neurológico</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Encéphale pathologie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Extrapyramidal syndrome</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Système nerveux central pathologie</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>41</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Cycle veille sommeil</s0>
<s5>42</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Sleep wake cycle</s0>
<s5>42</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Ciclo sueño vigilia</s0>
<s5>42</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE"><s0>Trouble humeur</s0>
<s5>43</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG"><s0>Mood disorder</s0>
<s5>43</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA"><s0>Trastorno humor</s0>
<s5>43</s5>
</fC07>
<fN21><s1>253</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
<server><NO>PASCAL 07-0391073 INIST</NO>
<ET>Characteristics of sleep disturbances in japanese patients with parkinson's disease. A study using Parkinson's disease sleep scale</ET>
<AU>SUZUKI (Keisuke); OKUMA (Yasuyuki); HATTORI (Nobutaka); KAMEI (Satoshi); YOSHII (Fumihito); UTSUMI (Hiroya); IWASAKI (Yasuo); IIJIMA (Mutsumi); MIYAMOTO (Tomoyuki); MIYAMOTO (Masayuki); HIRATA (Koichi)</AU>
<AF>Department of Neurology, Dokkyo Medical University/Tochigi/Japon (1 aut., 9 aut., 10 aut., 11 aut.); Department of Neurology, Juntendo University Shizuoka Hospital/Tokyo/Japon (2 aut.); Department of Neurology, Juntendo University School of Medicine/Tokyo/Japon (3 aut.); Division of Neurology, Department of Medicine, Nihon University School of Medicine/Tokyo/Japon (4 aut.); Department of Neurology, Tokai University School of Medicine/Kanagawa/Japon (5 aut.); Third Department of Internal Medicine, Division of Neurology , Tokyo Medical University, School of Medicine/Tokyo/Japon (6 aut.); Department of Neurology, Toho University Omori Hospital/Tokyo/Japon (7 aut.); Department of Neurology, Tokyo Women's Medical University/Tokyo/Japon (8 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2007; Vol. 22; No. 9; Pp. 1245-1251; Bibl. 32 ref.</SO>
<LA>Anglais</LA>
<EA>The present multicenter cross-sectional study was performed using semistructured questionnaires to determine the contributing factors of sleep disturbances in Japanese patients with Parkinson's disease (PD). We used the Parkinson's disease sleep scale (PDSS, Japanese version). All data were obtained by means of interviewed questionnaire and physical examination by neurologists. The study was carried out between April 2005 and December 2005 at eight university hospitals and affiliated facilities in the Kanto area of Japan. A total of 188 (85 men and 103 women) PD patients and 144 controls (64 men and 80 women) were included. Stepwise regression analysis identified complications of treatment, depression, age, and disease duration as significant risk factors of sleep disturbances in PD. Significant differences in total PDSS score were observed between Hoehn & Yahr (H&Y) Stages 1 and 4, between H&Y Stages 2 and 4, and between H&Y stages 3 and 4 (Bonferroni test). The results of this survey suggested that complications due to treatment (dyskinesia, wearing off, on-off), depressive state, and disease stage are significant determinants of sleep disorders in Japanese patients with PD. We speculate that the reduction of neurotransmitters involved in the sleep-wakefulness mechanism and degeneration of neurons progress together in parallel with deterioration of motor function.</EA>
<CC>002B17; 002B17G; 002B17A03</CC>
<FD>Système nerveux pathologie; Trouble sommeil; Parkinson maladie; Etat dépressif; Japonais; Homme; Sommeil; Complication; Traitement</FD>
<FG>Trouble neurologique; Encéphale pathologie; Extrapyramidal syndrome; Maladie dégénérative; Système nerveux central pathologie; Cycle veille sommeil; Trouble humeur</FG>
<ED>Nervous system diseases; Sleep disorder; Parkinson disease; Depression; Japanese; Human; Sleep; Complication; Treatment</ED>
<EG>Neurological disorder; Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Central nervous system disease; Sleep wake cycle; Mood disorder</EG>
<SD>Sistema nervioso patología; Trastorno sueño; Parkinson enfermedad; Estado depresivo; Japonés; Hombre; Sueño; Complicación; Tratamiento</SD>
<LO>INIST-20953.354000146732490060</LO>
<ID>07-0391073</ID>
</server>
</inist>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001623 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 001623 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= PascalFrancis |étape= Corpus |type= RBID |clé= Pascal:07-0391073 |texte= Characteristics of sleep disturbances in japanese patients with parkinson's disease. A study using Parkinson's disease sleep scale }}
![]() | This area was generated with Dilib version V0.6.23. | ![]() |